Viewing Study NCT05494866


Ignite Creation Date: 2025-12-24 @ 4:39 PM
Ignite Modification Date: 2026-01-24 @ 7:11 AM
Study NCT ID: NCT05494866
Status: TERMINATED
Last Update Posted: 2025-03-25
First Post: 2022-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor: German Cancer Research Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None CYP3A Inhibitor View
None Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma View
None Pancreatic Cancer View
None Pancreatic Adenocarcinoma View
None Pancreatic Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CYP3A Inhibitor View
None Pancreatic Ductal Adenocarcinoma View
None Adenocarcinoma View
None Carcinoma View
None Neoplasms, Glandular and Epithelial View
None Neoplasms by Histologic Type View
None Neoplasms View
None Cobicistat View
None Anti-HIV Agents View
None Anti-Retroviral Agents View
None Antiviral Agents View
None Anti-Infective Agents View
None Cytochrome P-450 CYP3A Inhibitors View
None Cytochrome P-450 Enzyme Inhibitors View
None Enzyme Inhibitors View
None Molecular Mechanisms of Pharmacological Action View